Status:
COMPLETED
Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease
Lead Sponsor:
Amgen
Conditions:
Kidney Disease
Chronic Kidney Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether darbepoetin alfa manufactured by the current "roller bottle" technology and darbepoetin alfa manufactured by a serum free process have a comparable sa...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Currently diagnosed with Chronic Kidney Disease, either receiving or not receiving dialysis
- Anemic
- Currently on erythropoietic therapy
- Controlled hypertension
- Clinically stable
Exclusion
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2007
Estimated Enrollment :
1100 Patients enrolled
Trial Details
Trial ID
NCT00093977
Start Date
October 1 2004
End Date
January 1 2007
Last Update
May 24 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.